Sign In | Join Free | My himfr.com
Home > POCT Instrument >

NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection

WWHS Biotech.Inc(exclusive marketed by Dawin)
Contact Now
    Buy cheap NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection from wholesalers
     
    Buy cheap NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection from wholesalers
    • Buy cheap NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection from wholesalers
    • Buy cheap NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection from wholesalers

    NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection

    Ask Lasest Price
    Brand Name : WWHS
    Model Number : NIR-1000
    Certification : ISO 13485, CE
    Price : Negotiable
    Payment Terms : T/T, L/C
    Supply Ability : 60 Sets per Day
    Delivery Time : 10 Days
    • Product Details
    • Company Profile

    NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection

    WWHS NIR-1000 Dry Fluorescent Immunoassay Analyser For D-Dimer Cardiac Detection


    The D-Dimer Rapid Quantitative Test along with WWHS Fluorescence Immunoassay Analyzer (FIA) is intended for vitro quantitative determination of D-Dimer in human whole blood or plasma.


    Description of WWHS NIR-1000 Dry Fluoroimmunoassay Analyser

    High Accuracy

    When the instrument tests the calibrated fluorescence test card, the deviation between the measured fluorescence value and the calibration value of the fluorescence test card is ±3.0%.

    Repeatability

    The variable coefficient of fluorescence value of fluorescence test cards of different intensities repeatedly measured by the instrument CV≤2.0%


    WWHS Assay List


    Cardiac     
    cat#.Product itemSpecimenReaction TimeMeasure RangeClinical RangeItended Use
    1cTnIWB/Serum/Plasma12min.0.1-40ng/ml<0.3ng/mlseveral heart diseases including myocardial infarction and heart failure.
    2MyoWB/Serum/Plasma12min.5-400ng/ml<58ng/mlacute myocardial infarction (AMI) in early stage.
    3CK-MBWB/Serum/Plasma12min.1-200ng/ml<5ng/mlacute myocardial infarction (AMI) in early stage.
    4NT-proBNPWB/Serum/Plasma10min.20-35000pg/mlUnder 75:0~347pg/mL,
    Over 75:0~449pg/mL
    heart failure .
    5D-DimerWB/Plasma10min.40-10000ng/ml<500ng/mldisseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
    6cTnI+Myo+CKMBWB/Serum/Plasma12min.same with single itemsame with single itemTriple marker of myocardial infarction.
    7ST2WB/Serum/Plasma10min.10-400ng/ml<35ng/mlheart failure .
    8Lp-PLA2WB/Serum/Plasma10min.10-900ng/ml<175ng/mlRisk evaluation of ACS and atherosclerotic ischemic stroke patients.
    9S100-βWB/Serum/Plasma10min.0.05-10ng/ml<0.2ng/mlCerebral infarction, cerebral injury.
    Inflammation     
    10CRP / hs-CRPWB/Serum/Plasma3min.0.5-200mg/LCRP<10mg/L,hs-CRP<1mg/Lnonspecficity inflammatory marker.
    11SAASerum5min.1-200mg/L<10mg/Linflammation&infection.
    12PCTWB/Serum/Plasma10min.0.2-100ng/ml<0.5ng/mlSepsis
    13CRP+SAAWB/Serum/Plasma5min.same with single itemsame with single iteminflammation&infection.
    14IL-6WB/Serum/Plasma10min.5-4000pg/ml10pg/mldiabetes,rheumatoid arthritis,etc
    Thyroid Hormone     
    15TSHSerum/Plasma15min.0.3-100mU/L0.35-5mU/Lhyperthyroidism and hypothyroidism
    16TT3Serum/Plasma15min.0.5-10nmol/L1.3-3.1nmol/Lthyroid dysfunction
    17TT4Serum/Plasma15min.5-300nmol/L66-181nmol/Lthyroid dysfunction
    18FT3Serum/Plasma15min.1-100pmol/L4-10pmol/Lthyroid dysfunction
    19FT4Serum/Plasma15min.5-300pmol/L19-39pmol/Lthyroid dysfunction
    Tumor Marker     
    20AFPSerum/Plasma15min.2.5-200ng/ml<20ng/mlpregnancy cancer
    21CEASerum/Plasma15min.1-200ng/ml<5ng/mlcolon cancer, colorectal cancer,etc.
    22NSESerum/Plasma15min.1-400ng/ml<16ng/mlnon-small cell lung cancer
    23FOBfecal specimens10min.50-1000ng/ml<100ng/mlAbnormal recessive gastrointestinal bleeding
    24PG IISerum/Plasma15min.1-100ug/LPGI/PGII>3.0gastric abnormalities
    25PG ISerum/Plasma15min.2.5-200ug/L>70ng/mlgastric abnormalities
    26TPSASerum/Plasma15min.0.5-40ng/ml<4ng/mlprostate cancer
    27FPSASerum/Plasma15min.0.1-10ng/ml<1ng/mlprostate cancer
    28CA12-5Serum/Plasma15min.20-500U/ml<35U/mlovarian cancer
    29CA15-3Serum/Plasma15min.10-400U/ml< 25 U/mLbreast cancer
    30HE4Serum/Plasma15min.50-2000pmol/L<140 pmol/Lovarian cancer
    31CA19-9Serum/Plasma15min.10-400U/ml< 27 U/mLpancreatic cancer
    32β-HCGSerum/Plasma15min.5-400mIU/ml<10 mIU/mLEarly pregrancy, ectopic HCG cancer,incomplete abortion
    33CK19(Cyfra21-1)Serum/Plasma15min.0.5-50ng/ml<2.5ng/mlnon-small cell lung cancer
    Fertility     
    34HCG / β-HCGSerum/Plasma10min.5-20000mIU/ml<5 mIU/mLearly pregrancy.
    35AMHSerum/Plasma10min.0.1-16ng/mlMale: 20-60 years old, 0.92-13.89 ng/mL
    Female: 20-29 years old, 0.88-10.35 ng/mL
    30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
    ovarian reserve level
    Gastrointestinal      
    36FOBfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    37TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    38FOB+TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    Infection      
    39C.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeCP infection
    40M.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeMP infection
    41Covid-19 Antigennasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    42Covid-19 Ab IgG/IgMWB/Serum/Plasma15min.qualitativequalitativerespiratory tract
    43FluAnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    44FluBnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    Renal Injury      
    45CysCWB/Serum/Plasma5min.0.4-9mg/L0.5-1.1mg/Lrenal function
    46NGALUrine10min.10-1500ng/mL<132ng/mLacute kidney injury.
    Other      
    47FERRSerum5min.10-500ng/mlMale:24ng/mL~335ng/mL,
    Female:11ng/mL~307ng/mL
    iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
    48HbA1cWB10min.4%-14%4%-6%diabetes
    49VDSerum/Plasma15min.8-70ng/mL19-57ng/mLfetation

    NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac DetectionNIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection


    Notice


    1) The test card can be used only once at room temperature, do not reuse or use test card out of expiry date.

    2) Return all reagents and sample into room temperature before use.

    3) Be careful when prepare sample, wear glove and mask.

    4) The whole blood need add anticoagulants, not frozen; serum sample can store in frozen, avoid repeated freezing and thawing.

    5) This product is only for in vitro rapid diagnostic human use, can be quantified, not only qualitative testing.

    6) The product test results for reference only, for confirmation, please refer to the relevant national standard methods.


    Reagent Storage and expiry date


    Storage: Store at 4-30 ℃ in dark, sealed, dry place, no frozen.

    Expiry date: 12 months; date of production is on box.


    Package and Delivery


    Packing Details : Standard carton package or as demand.
    Delivery Details : 5-15days after payment

    We support a variety of transportation modes, including land

    transportation, sea transportation, air transportation, DHL, Fedex,TNT and other international logistics express.


    Quality NIR-1000 Dry Fluorescence Immunoassay Analyzer For D-Dimer Cardiac Detection for sale
    Inquiry Cart 0
    Send your message to this supplier
     
    *From:
    *To: WWHS Biotech.Inc(exclusive marketed by Dawin)
    *Subject:
    *Message:
    Characters Remaining: (0/3000)